Prioritizing the Continuing Global Challenges to Emerging and Reemerging Viral Infections

Schwartz, David A.

doi:10.3389/fviro.2021.701054

Cited by 4 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additional viruses not mentioned in the WHO Priority List include additional bunyaviruses, influenza virus strains, enteroviruses and poxviruses [87]. A recent review of emerging and re-emerging viral infections by Schwartz [88] also mentions, among other viruses, Lassa virus, Ebola virus, Marburg virus, Zika virus, SARS-CoV-2, MERS-CoV, and SARS-CoV, and Rift Valley fever virus. Knowledge gaps outlined in that review did not include gaps in information on disinfection/ surface hygiene and hand hygiene.…”

Section: Discussionmentioning

confidence: 99%

Predicted and Measured Virucidal Efficacies of Microbicides for Emerging and Re-emerging Viruses Associated with WHO Priority Diseases

Ijaz¹,

Nims²,

Cutts³

et al. 2022

Disinfection of Viruses

View full text Add to dashboard Cite

The World Health Organization has updated its list of priority diseases for 2021 to currently include the following: Ebola virus disease and Marburg virus disease (Filoviridae), Nipah and henipaviral diseases (Paramyxoviridae), Lassa fever (Arenaviridae), Rift Valley fever and Crimean-Congo hemorrhagic fever (Bunyaviridae), Zika (Flaviviridae), COVID-19 (SARS-CoV-2) including Delta, Omicron, and other variants of concern, Middle East respiratory syndrome, severe acute respiratory syndrome (Coronaviridae), and the always present “disease X,” which is a term used for the next emerging pathogen of concern that is not known about today. In this chapter, we review the virucidal efficacy data for microbicides (disinfectants and antiseptics, also known as surface and hand hygiene agents or collectively hygiene agents) for the viruses associated with these diseases. As these diseases are each caused by lipid-enveloped viruses, the susceptibilities of the viruses to virucidal agents are informed by the known hierarchy of susceptibility of pathogens to microbicides. The unique susceptibility of lipid-enveloped viruses to most classes of microbicides is based on the common mechanism of action of envelope-disrupting microbicides. Empirical data supporting this principle and the mitigational role of targeted hygiene in infection prevention and control (IPAC) discussed are presented.

show abstract

Section: Discussionmentioning

confidence: 99%

Predicted and Measured Virucidal Efficacies of Microbicides for Emerging and Re-emerging Viruses Associated with WHO Priority Diseases

Ijaz¹,

Nims²,

Cutts³

et al. 2022

Disinfection of Viruses

View full text Add to dashboard Cite

show abstract

“…Due to their diversity and capacity of adaptation, viruses can cause unpredictable epidemics and pandemics. The emergence and spread of viral pandemics has increased dramatically over the past twenty years, due to animal migration, disruption of ecological niches, facilitated cross-species contacts, mundialization and increased travels around the world [2] . These changes have enabled viruses to spread faster and wider, leading to a higher chance to encounter a profitable viral population to emerge and evolve.…”

Section: Introductionmentioning

confidence: 99%

Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses

Zwygart¹,

Medaglia²,

Huber³

et al. 2023

Biomedicine & Pharmacotherapy

View full text Add to dashboard Cite

Plausible reasons for the resurgence of Mpox (formerly Monkeypox): an overview

Zebardast,

Latifi,

Shafiei-Jandaghi

et al. 2023

Trop Dis Travel Med Vaccines

View full text Add to dashboard Cite

Poxviruses are large and diversified viruses that cause an emerging zoonotic disease known as monkeypox (mpox). In the past, mpox predominated primarily in the rural rainforests of Central and West Africa. Recently, the exportation of mpoxv from Africa to other continents has been progressively reported. However, the lack of travel history to Africa in most of the currently reported cases in 2022 promotes the sign of changing epidemiology of this disease. Concerns over the geographic distribution and continued resurgence of mpox is growing. In this review, we addressed the geographic distribution, transmission, reasons for the resurgence of mpox, and vaccination. Although the precise cause of the resurgence in mpox cases is mostly unknown, several suggested factors are believed to be waning immunity, accumulation of unvaccinated people, ecological conditions, risk behaviors of men who have sex with men, and genetic evolution.

show abstract

Prioritizing the Continuing Global Challenges to Emerging and Reemerging Viral Infections

Cited by 4 publications

References 29 publications

Predicted and Measured Virucidal Efficacies of Microbicides for Emerging and Re-emerging Viruses Associated with WHO Priority Diseases

Predicted and Measured Virucidal Efficacies of Microbicides for Emerging and Re-emerging Viruses Associated with WHO Priority Diseases

Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses

Plausible reasons for the resurgence of Mpox (formerly Monkeypox): an overview

Contact Info

Product

Resources

About